The glomerular expression levels of CCL2 and its receptor CCR2 were found to be elevated in human glomerulopathies (85), and CCL2/CCR2 signaling may mediate the development of a variety of glomerular diseases. This evidence concerns the gene CCL2 and lipoprotein glomerulopathy.